Search for: "Astrazeneca" Results 1 - 20 of 1,247
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 May 2024, 12:38 am by JR Chaves
Ha sido sonado el caso de la demanda colectiva en Londres por los perjuicios ocasionados por la vacuna AstraZeneca y que está pendiente de resolverse por sentencia. [read post]
20 May 2024, 7:30 am by Class Action Defense
District Court for the Northern District of Illinois conditionally certified a collective action of female workers employed by AstraZeneca, and approved notice to be sent to female sales … Continue reading "Plaintiffs Win Conditional Certification In Gender Bias Lawsuit Against AstraZeneca" [read post]
9 May 2024, 8:00 am by Leslie Eastman
The post AstraZeneca Withdraws COVID Vaccine from the Global Market first appeared on Le·gal In·sur·rec·tion. [read post]
30 Apr 2024, 4:00 pm by Leslie Eastman
The post AstraZeneca Admits That its Covid Vaccine Can Cause Blood Clotting Side Effect first appeared on Le·gal In·sur·rec·tion. [read post]
Prior to his role at Astellas, Kats was at the forefront leading HR at several pharmaceutical and technology sectors (Johnson & Johnson, AstraZeneca, Microsoft, etc.). [read post]
18 Mar 2024, 9:46 am by Kalvis Golde
AstraZeneca Pharmaceuticals, LP 23-665Issue: Whether, where an unemployment applicant’s religious beliefs are independently sufficient to cause her refusal to follow an employer policy, a state can deny her unemployment benefits by holding that philosophical and personal beliefs outweigh her religious beliefs. [read post]
12 Mar 2024, 6:17 pm by Kurt R. Karst
” Taking the opposite approach, AstraZeneca, Boehringer Ingelheim, Abbvie, Mylan/Viatris, and Teva all refused to delist the patents referenced by FTC and Congress. [read post]
12 Mar 2024, 12:46 pm by admin
Astrazeneca Pharms., LP, 500 F. [read post]
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
10 Mar 2024, 10:00 pm
The US District Court of Delaware recently ruled against AstraZeneca in its case challenging the constitutionality of Medicare’s new Drug Price Negotiation Program (the Program). [read post]
5 Mar 2024, 10:55 am by Evangelina Cantu
., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
4 Mar 2024, 7:03 am by FRANK VINLUAN - MEDCITY NEWS
The post AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation By Medicare appeared first on Above the Law. [read post]
29 Feb 2024, 9:01 am by Seeger Weiss
Additionally, they played a role in negotiating a $425 million settlement to resolve allegations in both federal and state courts that AstraZeneca’s acid reflux medications Nexium and Prilosec led to kidney injuries “What makes the firm stand out is that they take cases with the intention of trying the case to the end,” Seeger said. [read post]
20 Feb 2024, 8:25 am by Tom Smith
The report specifically looked at adverse events following administration of the Pfizer, Moderna and AstraZeneca vaccines. [read post]